Dyne Therapeutics, Inc.(NasdaqGS:DYN) dropped from Russell 3000E Growth Index
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.8 USD | -5.33% |
|
+5.50% | +213.72% |
07-09 | JPMorgan Adjusts Price Target on Dyne Therapeutics to $43 From $39, Maintains Overweight Rating | MT |
07-01 | Dyne Therapeutics, Inc.(NasdaqGS:DYN) dropped from Russell Small Cap Comp Value Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+213.72% | 4.38B | |
+24.42% | 47.96B | |
-0.10% | 42.45B | |
+43.96% | 41.47B | |
+26.34% | 31.6B | |
+19.09% | 28.63B | |
-4.47% | 28.03B | |
+51.71% | 14.56B | |
+43.73% | 14.14B | |
+2.07% | 12.58B |
- Stock Market
- Equities
- DYN Stock
- News Dyne Therapeutics, Inc.
- Dyne Therapeutics, Inc.(NasdaqGS: DYN) dropped from Russell 3000E Growth Index